Last reviewed · How we verify
NCT04574323
Effects of a Paleolithic Lifestyle Intervention in Breast Cancer Patients Undergoing Radiotherapy
NA trial testing Curative radiotherapy in Breast Cancer in 13 participants. Completed in 16 July 2020.
13 June 2020
Quick facts
| Lead sponsor | MVZ Leopoldina GmbH |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 13 |
| Start date | 19 March 2020 |
| Primary completion | 13 June 2020 |
| Estimated completion | 16 July 2020 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Curative radiotherapy
- Paleolithic lifestyle intervention
Conditions studied
- Breast Cancer — all drugs for Breast Cancer →
- Body Weight Changes — all drugs for Body Weight Changes →
Sponsor
MVZ Leopoldina GmbH
Who can join
Adults 18 to 75, female only, with Breast Cancer or Body Weight Changes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study aims to test the feasibility and effects of a dietary and physical activity intervention based on evolutionary considerations in an oncological setting.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential.
Xiao YL, Gong Y, Qi YJ, Shao ZM, et al · · 2024 · cited 120× · PMID 38462638 · DOI 10.1038/s41392-024-01771-x -
Low Vitamin D Status in a Cancer Patient Population from Franconia, Germany.
Klement RJ, Koebrunner PS, Krage K, Sweeney RA. · · 2021 · cited 2× · PMID 33316808 · DOI 10.1159/000511993
Verify or expand the search:
- PubMed search for NCT04574323
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Curative radiotherapy
Trials testing the same drug.
- NCT05861362 — Feasibility and Metabolic Effects of a 5:2 Fasting Intervention in Women With Breast Cancer During Radiotherapy · NA · completed
Other recruiting trials for Breast Cancer
Currently open trials in the same condition.
- NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
- NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
- NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
- NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
- NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting
Other MVZ Leopoldina GmbH trials
Trials by the same sponsor.
- NCT05861362 — Feasibility and Metabolic Effects of a 5:2 Fasting Intervention in Women With Breast Cancer During Radiotherapy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04574323 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by MVZ Leopoldina GmbH
- Last refreshed: 4 December 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04574323.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing